{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:40:29Z","timestamp":1787452829943,"version":"build-2736575974"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Alzheimer\u2019s disease (AD), the predominant cause of late-life dementia, has a multifactorial etiology. Since there are few therapeutic options for symptomatic AD, research is increasingly focused on the identification of pre-symptomatic biomarkers. Recently, evaluation of neuron-derived exosomal markers has emerged as a promising novel approach for determining neuronal dysfunction. We aimed to identify novel neuron-derived exosomal markers that signify a transition from normal aging to Mild Cognitive Impairment (MCI) and then to clinically established AD, a sequence we refer to as AD progression. By using a Tandem Mass Tag-based quantitative proteomic approach, we identified a total of 360 neuron-derived exosomal proteins. Subsequent fuzzy c-means clustering revealed two clusters of proteins displaying trends of gradually increasing\/decreasing expression over the period of AD progression (normal to MCI to AD), both of which were mainly involved in immune response-associated pathways, proteins within these clusters were defined as bridge proteins. Several differentially expressed proteins (DEPs) were identified in the progression of AD. The intersections of bridge proteins and DEPs were defined as key proteins, including C7 (Complement component 7), FERMT3 (Fermitin Family Member 3), CAP1 (Adenylyl cyclase-associated protein 1), ENO1 (Enolase 1), and ZYX (Zyxin), among which the expression patterns of C7 and ZYX were almost consistent with the proteomic results. Collectively, we propose that C7 and ZYX might be two novel neuron-derived exosomal protein markers, expression of which might be used to evaluate cognitive decline before a clinical diagnosis of AD is warranted.<\/jats:p>","DOI":"10.3389\/fnagi.2021.696944","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T12:32:52Z","timestamp":1630413172000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Discovery of Novel Markers for Identifying Cognitive Decline Using Neuron-Derived Exosomes"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiacheng","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulin","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"186fs119","DOI":"10.1126\/scitranslmed.3006288","article-title":"Autoantibodies: double agents in human disease","volume":"5","author":"Acharya","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.7508\/ibj.2016.02.003","article-title":"Identification of sequence variation in the apolipoprotein A2 gene and their relationship with serum high-density lipoprotein cholesterol levels","volume":"20","author":"Bandarian","year":"2016","journal-title":"Iran Biomed. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphys.2012.00124","article-title":"Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases?","volume":"3","author":"Bellingham","year":"2012","journal-title":"Front. Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/0197-4580(89)90085-7","article-title":"Evidence for etiologic heterogeneity in Alzheimer\u2019s disease","volume":"10","author":"Bird","year":"1989","journal-title":"Neurobiol. Aging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1111\/j.1471-4159.2009.06397.x","article-title":"Multifunctional roles of enolase in Alzheimer\u2019s disease brain: beyond altered glucose metabolism","volume":"111","author":"Butterfield","year":"2009","journal-title":"J. Neurochem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3233\/JAD-121621","article-title":"Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1 and SLC2A8 among fast progressors in early Alzheimer\u2019s disease","volume":"34","author":"Chong","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1158\/0008-5472.CAN-10-3486","article-title":"Zyxin is a critical regulator of the apoptotic HIPK2\u2013p53 signaling axis","volume":"71","author":"Crone","year":"2011","journal-title":"Cancer Res."},{"key":"B1000","doi-asserted-by":"publisher","first-page":"D1145","DOI":"10.1093\/nar\/gkz984","article-title":"The ProteomeXchange consortium in 2020: enabling \u2018big data\u2019 approaches in proteomics","volume":"48","author":"Deutsch","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13195-018-0455-y","article-title":"Heterogeneity of Alzheimer\u2019s disease: consequence for drug trials?","volume":"10","author":"Devi","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neubiorev.2019.06.018","article-title":"Gene-by-environment interactions in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"103","author":"Dunn","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/1715163517690745","article-title":"Dementia: what pharmacists need to know","volume":"150","author":"Duong","year":"2017","journal-title":"Can. Pharm. J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2121-10-6","article-title":"Zyxin is a novel interacting partner for SIRT1","volume":"10","author":"Fujita","year":"2009","journal-title":"BMC Cell Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1084\/jem.177.4.1181","article-title":"Human antibodies reactive with \u03b2-amyloid protein in Alzheimer\u2019s disease","volume":"177","author":"Gaskin","year":"1993","journal-title":"J. Exp. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11920-012-0291-x","article-title":"Mild cognitive impairment in older adults","volume":"14","author":"Geda","year":"2012","journal-title":"Curr. Psychiatry Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1096\/fj.201700731R","article-title":"Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer\u2019s disease","volume":"32","author":"Goetzl","year":"2018","journal-title":"FASEB J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1096\/fj.201600816R","article-title":"Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer\u2019s disease","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.it.2016.10.003","article-title":"Antigen presentation to B cells","volume":"37","author":"Heesters","year":"2016","journal-title":"Trends Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1177\/1947601910376192","article-title":"The LIM protein zyxin binds CARP-1 and promotes apoptosis","volume":"1","author":"Hervy","year":"2010","journal-title":"Genes Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.bcp.2014.01.003","article-title":"Future directions in Alzheimer\u2019s disease from risk factors to prevention","volume":"88","author":"Imtiaz","year":"2014","journal-title":"Biochem Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1172\/JCI24280","article-title":"Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt","volume":"115","author":"Kato","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0895-4356(88)90034-0","article-title":"A Chinese version of the mini-mental state examination; impact of illiteracy in a Shanghai dementia survey","volume":"41","author":"Katzman","year":"1988","journal-title":"J. Clin. Epidemiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3233\/JAD-150238","article-title":"Alzheimer\u2019s disease cerebrospinal fluid and neuroimaging biomarkers: diagnostic accuracy and relationship to drug efficacy","volume":"46","author":"Khan","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.6026\/97320630002005","article-title":"Mfuzz: a software package for soft clustering of microarray data","volume":"2","author":"Kumar","year":"2007","journal-title":"Bioinformation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/jnc.12154","article-title":"Zyxin is a novel target for \u03b2-amyloid peptide: characterization of its role in Alzheimer\u2019s pathogenesis","volume":"125","author":"Lanni","year":"2013","journal-title":"J. Neurochem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","article-title":"An update on blood-based markers of Alzheimer\u2019s disease using the SiMoA platform","volume":"8","author":"Li","year":"2019","journal-title":"Neurol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"657086","DOI":"10.1155\/2015\/657086","article-title":"Exosomes: novel biomarkers for clinical diagnosis","volume":"2015","author":"Lin","year":"2015","journal-title":"Sci. World J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"a002295","DOI":"10.1101\/cshperspect.a002295","article-title":"It\u2019s all about change: the antigen-driven initiation of B-cell receptor signaling","volume":"2","author":"Liu","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4161\/chan.27471","article-title":"The role of ryanodine receptor type 3 in a mouse model of Alzheimer disease","volume":"8","author":"Liu","year":"2014","journal-title":"Channels"},{"key":"B31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13195-018-0361-3","article-title":"Cerebrospinal fluid in the differential diagnosis of Alzheimer\u2019s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic","volume":"10","author":"Paterson","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"B1001","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","article-title":"Complement in immune and inflammatory disorders: pathophysiological mechanisms","volume":"190","author":"Ricklin","year":"2013","journal-title":"J. Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/156720509788929273","article-title":"Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort","volume":"6","author":"Risacher","year":"2009","journal-title":"Curr. Alzheimer Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40120-019-00171-6","article-title":"Peripheral biomarkers for Alzheimer\u2019s disease: update and progress","volume":"8","author":"Sabbagh","year":"2019","journal-title":"Neurol. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12883-018-1160-y","article-title":"Salivary \u03b2 amyloid protein levels are detectable and differentiate patients with Alzheimer\u2019s disease dementia from normal controls: preliminary findings","volume":"18","author":"Sabbagh","year":"2018","journal-title":"BMC Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"23975","DOI":"10.1039\/d0ra02414g","article-title":"Use of exosomes as vectors to carry advanced therapies","volume":"10","author":"Sancho-Albero","year":"2020","journal-title":"RSC Adv."},{"key":"B37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"16086","DOI":"10.1073\/pnas.1902513116","article-title":"Exosomes regulate neurogenesis and circuit assembly","volume":"116","author":"Sharma","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jprot.2015.04.005","article-title":"Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer\u2019s disease mice at its earliest pathological stage","volume":"123","author":"Shen","year":"2015","journal-title":"J. Proteomics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e34078","DOI":"10.1371\/journal.pone.0034078","article-title":"Plasma apolipoprotein levels are associated with cognitive status and decline in a community cohort of older individuals","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.socscimed.2017.05.017","article-title":"Expectant futures and an early diagnosis of Alzheimer\u2019s disease: knowing and its consequences","volume":"184","author":"Swallow","year":"2017","journal-title":"Soc. Sci. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.4049\/jimmunol.1901068","article-title":"Complement-mediated events in Alzheimer\u2019s disease: mechanisms and potential therapeutic targets","volume":"204","author":"Tenner","year":"2020","journal-title":"J. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1016\/j.molimm.2008.04.025","article-title":"C4b-binding protein in Alzheimer\u2019s disease: binding to A\u03b21\u201342 and to dead cells","volume":"45","author":"Trouw","year":"2008","journal-title":"Mol. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0182844","DOI":"10.1371\/journal.pone.0182844","article-title":"Time-course global proteome analyses reveal an inverse correlation between A\u03b2 burden and immunoglobulin M levels in the APPNL-F mouse model of Alzheimer disease","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13024-019-0317-5","article-title":"Neuronally derived extracellular vesicles: an emerging tool for understanding Alzheimer\u2019s disease","volume":"14","author":"Watson","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B46","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.14506.1","article-title":"Current understanding of Alzheimer\u2019s disease diagnosis and treatment","volume":"7","author":"Weller","year":"2018","journal-title":"F1000Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.7150\/thno.41580","article-title":"Progress, opportunity and perspective on exosome isolation\u2014efforts for efficient exosome-based theranostics","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/nsr\/nwy127","article-title":"Complement C7 is a novel risk gene for Alzheimer\u2019s disease in Han Chinese","volume":"6","author":"Zhang","year":"2019","journal-title":"Natl. Sci. Rev."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.696944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T12:32:58Z","timestamp":1630413178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.696944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":50,"alternative-id":["10.3389\/fnagi.2021.696944"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.696944","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"article-number":"696944"}}